TABLE 1.
Demographic and baseline data
| Soy protein | Placebo | |
|---|---|---|
| Evaluable subjects, n | 50 | 43 |
| Age,1 y | 60.6 (58.8, 62.4) | 62.5 (60.4, 64.6) |
| Body weight,1,2 kg | 86.9 (82.1, 89.9) | 90.0 (85.0, 95.1) |
| BMI,1,3 kg/m2 | 27.4 (26.2, 28.5) | 28.2 (26.8, 29.7) |
| Race4 | ||
| White (Caucasian) | 47 (94%) | 38 (89%) |
| African American | 2 (4%) | 2 (5%) |
| Hispanic | 1 (2%) | 1 (2%) |
| Asian | 0 | 1 (2%) |
| Other (Pacific Islander) | 0 | 1 (2%) |
| Hospital | ||
| Tisch Hospital | 44 (88%) | 39 (91%) |
| Manhattan VA | 5 (10%) | 4 (9%) |
| Other | 1 (2%) | 0 |
| Subjects not on cholesterol-lowering medication4 | 34 (68%) | 22 (51%) |
| Subjects not on antihypertensive medication4 | 29 (58%) | 22 (51%) |
| Subjects not on any medication4 | 13 (26%) | 10 (23%) |
1
Values are means (95% CIs).
2
Body weight data are missing for 2 subjects in the soy protein group and 1 subject in the placebo group.
3
BMI data are missing for 5 subjects in the soy protein group and 3 subjects in the placebo group because of missing weight and/or height data.
4
Self-reported.